Skip to main content
. 2018 Nov 30;16(4):469–480. doi: 10.9758/cpn.2018.16.4.469

Fig. 3.

Fig. 3

The proportion of patients those achieved 2 or less in Frequency, Intensity, and Burden of Side Effects Ratings sub-scores at the end of treatment.

PGATx, pharmacogenomic-based antidepressant treatment; TAU, treatment as usual.